Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Mil-125-Based Nanocarrier Decorated With Palladium Complex for Targeted Drug Delivery Publisher Pubmed



Bagherzadeh M1 ; Safarkhani M1 ; Kiani M1 ; Radmanesh F2, 3 ; Daneshgar H1 ; Ghadiri AM1 ; Taghavimandi F1 ; Fatahi Y4, 5, 6 ; Safarialighiarloo N7 ; Ahmadi S8 ; Rabiee N9, 10
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Chemistry, Sharif University of Technology, Tehran, Iran
  2. 2. Uro-Oncology Research Center, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Department of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran
  4. 4. Nanotechnology Research Centre, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
  5. 5. Department of Pharmaceutical Nanotechnology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
  6. 6. Universal Scientific Education and Research Network (USERN), Tehran, Iran
  7. 7. Endocrine Research Center, Institute of Endocrinology and Metabolism, Iran University of Medical Sciences, Tehran, Iran
  8. 8. Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  9. 9. School of Engineering, Macquarie University, Sydney, 2109, NSW, Australia
  10. 10. Department of Materials Science and Engineering, Pohang University of Science and Technology (POSTECH), 77 Cheongam-ro, Nam-gu, Gyeongbuk, Pohang, 37673, South Korea

Source: Scientific Reports Published:2022


Abstract

The aim of this work was to provide a novel approach to designing and synthesizing a nanocomposite with significant biocompatibility, biodegradability, and stability in biological microenvironments. Hence, the porous ultra-low-density materials, metal–organic frameworks (MOFs), have been considered and the MIL-125(Ti) has been chosen due to its distinctive characteristics such as great biocompatibility and good biodegradability immobilized on the surface of the reduced graphene oxide (rGO). Based on the results, the presence of transition metal complexes next to the drug not only can reinforce the stability of the drug on the structure by preparing π–π interaction between ligands and the drug but also can enhance the efficiency of the drug by preventing the spontaneous release. The effect of utilizing transition metal complex beside drug (Doxorubicin (DOX)) on the drug loading, drug release, and antibacterial activity of prepared nanocomposites on the P. aeruginosa and S. aureus as a model bacterium has been investigated and the results revealed that this theory leads to increasing about 200% in antibacterial activity. In addition, uptake, the release of the drug, and relative cell viabilities (in vitro and in vivo) of prepared nanomaterials and biomaterials have been discussed. Based on collected data, the median size of prepared nanocomposites was 156.2 nm, and their biological stability in PBS and DMEM + 10% FBS was screened and revealed that after 2.880 min, the nanocomposite’s size reached 242.3 and 516 nm respectively. The MTT results demonstrated that immobilizing PdL beside DOX leads to an increase of more than 15% in the cell viability. It is noticeable that the AST:ALT result of prepared nanocomposite was under 1.5. © 2022, The Author(s).
Other Related Docs
17. Polymer-Coated Nh2-Uio-66 for the Codelivery of Dox/Pcrispr, ACS Applied Materials and Interfaces (2021)
18. Adsorption, Delivery, and Controlled Release of Therapeutic Molecules From Mofs, Metal-Organic Frameworks for Biomedical Applications (2020)
21. Nanomil-100(Fe) Containing Docetaxel for Breast Cancer Therapy, Artificial Cells# Nanomedicine and Biotechnology (2018)
22. Multifunctional 3D Hierarchical Bioactive Green Carbon-Based Nanocomposites, ACS Sustainable Chemistry and Engineering (2021)